News & Updates
Mounjaro Overtakes Keytruda as World's Top Drug
Eli Lilly's Mounjaro (tirzepatide) has surpassed Merck's Keytruda to become the world's top-selling drug, a milestone that signals a dramatic shift in how medicine treats obesity and type 2 diabetes. For patients researching GLP-1 medications, this news carries real implications for supply, pricing, and access. Here is what you need to know.